Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa

Completed

Conditions studied: Glycogen Storage Disease Type IA

In brief

The primary objective of this study is to assess the percentage of time patients were in normal glucose control.

Key facts

Study ID

NCT04708015

Run by

Ultragenyx Pharmaceutical Inc

People needed

15

Starts

2020-11-05

Expected to finish

2022-03-04

Last updated by the study team

2024-05-29

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of GSDIa confirmed by either liver biopsy or molecular testing.
• Currently using the Dexcom G6 iCGM for glycemic control and with approximately one (1) month of CGM data available on the Dexcom Clarity cloud and have authorized sharing of data with thereferral center through the Dexcom Clarity app.

You may not qualify if…

• Presence or history of any disease, condition or chronic medication that, in the Investigator's opinion, would significantly affect interpretation of study results.
• Use of any investigational product or investigational medical device within 30 calendar days preceding screening or before completion of all scheduled study assessments during study enrollment.

Where it is running

• UT Health - McGovern Medical School — Houston, Texas, United States
• University Medical Center Groningen — Groningen, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.